FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stent, Superficial Femoral Artery, Drug-Eluting

PMA: P180011 · Supplement: S028 · Decision May 19, 2020
Classifications
1
FEI Numbers
9
Registration Numbers
9

Basic Information

Device Name
Stent, Superficial Femoral Artery, Drug-Eluting
Trade Name
Eluvia Drug-Eluting Vascular Stent System
PMA Number
P180011
Supplement Number
S028
Device Class
FDA Class 3
Product Code
NIU
Generic Name
Stent, superficial femoral artery, drug-eluting
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
May 19, 2020
Date Received
March 12, 2020
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Approval for a manufacturing site located at Boston Scientific Corp. in Ballybrit Business Park Galway, Ireland for sterilization.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NIU Stent, Superficial Femoral Artery, Drug-Eluting